NCT01430455View on ClinicalTrials.gov

Tranylcypromine Treatment of Bipolar Depression

PHASE4CompletedINTERVENTIONAL
Enrollment

7

Participants

Timeline

Start Date

November 30, 2011

Primary Completion Date

February 28, 2014

Study Completion Date

September 30, 2014

Conditions
Bipolar Disorder I or II
Interventions
DRUG

Tranylcypromine

Tranylcypromine, between 10 mg/day and 120 mg/day throughout 16 week study

Trial Locations (1)

10032

New York State Psychiatric Institute, New York

All Listed Sponsors
lead

New York State Psychiatric Institute

OTHER

NCT01430455 - Tranylcypromine Treatment of Bipolar Depression | Biotech Hunter | Biotech Hunter